VVB (维眸生物)

Biotech company Weimou Biotech (维眸生物) has submitted an initial public offering (IPO) application to the Hong Kong Stock Exchange (HKEX). The Zhejiang-based company has appointed China International Capital Corporation (CICC) as the sole sponsor for its planned listing.

AI-generated: summaries written by AI from the linked sources. How we use AI